Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

View:
Post by scaley on Jun 25, 2020 12:00pm

Hmmm

Things are happening. There is more going on then just the financials . I expect great things to come. A news release ( or 2) to tie into the halt and future. Remember- everything science related has been stellar with kaly. We knew all about the financial situation long before this halt. Let the science take its course, the stars will align.
Comment by Random1234 on Jun 25, 2020 12:18pm
In my opinion, Company deliberalty did not file the tax, as they were expecting to take over SALZMAN. Filing tax and taking over Salzman is the cause of  this halt.  I feel, If this taking over process happens, then there must be RS of 20:1. In my view, before this RS, company should increase the SP upto 10 cents and then do RS to take it to $1. If they do RS first then it will be hard ...more  
Comment by Chritters on Jun 25, 2020 12:22pm
I kinda wish it was Salzman Taking over Kaly. The Management team in Kaly are terrible.
Comment by Random1234 on Jun 25, 2020 12:39pm
You are right, however unfortunate part is, all wishes does not come true.  KLY has long  history, and Salzman is a private company.  KLY will takeover and this is the reason of RS. I dont know, my intention is my investment.  looking forward to have something good for all of us
Comment by Chritters on Jun 25, 2020 1:01pm
You and me both I currently only hold 109,000 Shares at 0.025 so every half percentage it rises I make $550.00 I am happy with that. I'm still out of work or I would have bought more and average down even more. Be nice if the Halt comes off tonight.
Comment by Random1234 on Jun 25, 2020 1:30pm
My avg buying is like 4 cents. and have 500K
Comment by Chritters on Jun 25, 2020 4:03pm
Not to shabby at all..
Comment by s3binator on Jun 25, 2020 12:41pm
This is whats happening. Why would a succesful private company let a Kal take over. This is an efficient and cheap way for Salzman to go public. The deal is Salzman helping Kaly, with mutual beneficial merger.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities